Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec & Sanofi Launch LAB031 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec & Sanofi Launch LAB031

BRIDGE LAB031 allows for early-stage translational projects addressing indications in diseases with a high unmet medical need

By: Betsy Louda

, Contract Pharma

Evotec AG has established an initiative with Sanofi through the launch of a newly created BRIDGE, called LAB031, designed to accelerate drug discovery across multiple therapeutic areas.  

The BRIDGE LAB031 collaboration enables Evotec to access resources to enter research collaborations with academic institutions worldwide to collaborate on early-stage translational projects addressing indications in disease areas with a high unmet medical need. Over the next three years, the companies will focus on the generation and advancement of multiple small molecule programs through the lead optimization.  

For each project, Sanofi has the option to assume development responsibility upon the achievement of pre-agreed milestone criteria.  

Dr Werner Lanthaler, chief executive officer of Evotec, said, “This BRIDGE announced today is another strategic expansion of Evotec’s relationship with Sanofi. Supporting academic initiatives globally through BRIDGEs is designed to enable Evotec to validate translational ideas more efficiently.”  

“We are pleased to expand our relationship with Evotec and establish LAB031. Sanofi is focused on identifying the best resources available in order to translate academic innovation into clinical assets,” said Shiv Krishnan, Head of Technology Platforms, Global Business Development & Licensing, at Sanofi.  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics